Ingredient record · Glucose solution used in drips
Dextrose: bans, restrictions and failed batches in India
Last checked 3 November 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Sep 2026
1 entry containing Dextrose is on India's banned-drugs list, and 1 is banned today. 40 batches of medicines containing Dextrose failed a government lab test between February 2019 and September 2026, from 31 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
1
Banned combinations in force
0
Other listed orders (stayed, restricted, quashed)
40
Batches failed a lab test
Sep 2026
Latest lab alert
On the banned-drugs list
Dextrose on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Patent and Proprietary Oral Rehydration Salts other than Those Conforming to the Following Parameters: (a) Patent and Proprietary Oral Rehydration Salts on Reconstitution to One Litre Shall Contain: Sodium, 50 to 90 Milliosmoles Total Osmolarity, 240-290 Milliosmoles Dextrose: Sodium Molar Ratio, not less than 1:1 and not More than 3:1 (B) Patent and Proprietary Cereal Based Oral Rehydration Salts on Reconstitution to One Litre Shall Contain: Sodium, 50 to 90 Milliosmoles Total Osmolarity, not More than 290 Milliosmoles Precooked Rice, Equivalent to not less than 50gms and not More than 80gms as Total Replacement of Dextrose (C) Patent and Proprietary Oral Rehydration Salts (ORS) May Contain Amino Acids in Addition to Oral Rehydration Salts Conforming to the Parameters Specified Above and Labelled with the Indication for "Adult Chloretic Diarrhea Only" (D) Patent and Proprietary Oral Rehydration Salts (ORS) Shall not Contain Mono or Polysaccharides or Saccharin Sweetening AgentFixed-dose combination · other | Banned | GSR 57(E) | 7 February 1995 | Classic bans | In force per CDSCO consumer list (1983-2017) |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Bupivacaine Hydrochloride in Dextrose | 15 | 12 | Sep 2026 |
| Sodium Chloride Dextrose | 6 | 5 | Sep 2026 |
| Multiple Electrolytes Dextrose Type I | 3 | 2 | Sep 2025 |
| Peritoneal Dialysis Dextrose | 2 | 1 | Sep 2026 |
| W/v Sodium Chloride Dextrose | 2 | 2 | Jun 2025 |
| Peritoneal Dialysis W/v Dextrose | 2 | 2 | Jan 2023 |
| Amino Acids Electrolytes Dextrose Intravenous Fat Emulsion Medium Long Chain Triglycerides in A Triple Chamber Bag | 1 | 1 | Jul 2026 |
| Dextrose W/v | 1 | 1 | Jun 2025 |
| Multiple Electrolytes Dextrose Type | 1 | 1 | May 2025 |
| Bupivaaine Hydrochloride in Dextrose | 1 | 1 | Feb 2025 |
| Dextrose Ascorbic Acid Zinc | 1 | 1 | Jul 2024 |
| Bupivacaine Hydrochloride in Dextrose Amp | 1 | 1 | Apr 2024 |
| Multielectrolyte W/v Dextrose Intalyte | 1 | 1 | Jul 2023 |
| Bupivacaine Heavy | 1 | 1 | May 2023 |
| Bupicain Heavy | 1 | 1 | Nov 2022 |
| Sodium Chloride Dextrose D Ns | 1 | 1 | Feb 2019 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Peritoneal Dialysis Solution with 2.5% Dextrose IP | Batch A25D043Mfg Apr 2025 · Exp Apr 2027 | Baxter Manufacturing (Thailand) Co. Ltd. Imported by- Baxter (India) Pvt. Ltd. No. Ambattur TalukTamil Nadu | The sample does not conforms to claim as per IP 2022 in respect to the Description, Appearance of Solution, Particulate Matter and Bacterial EndotoxinsDescription | DTL BADDIState lab | Sep 2026 |
| Peritoneal Dialysis Solution with 1.5% Dextrose IP | Batch A25E044Mfg May 2025 · Exp May 2027 | Baxter Manufacturing (Thailand) Co. Ltd. Imported by- Baxter (India) Pvt. Ltd. No. Ambattur TalukTamil Nadu | The sample does not conform to claim as per IP 2022 in respect to the Test of Bacterial EndotoxinsBacterial endotoxins | DTL BADDIState lab | Sep 2026 |
| Dextrose and Sodium Chloride Injection I.P. | Batch F51528Mfg Dec 2025 · Exp Nov 2028 | Higgs HealthcareHimachal Pradesh | The sample does not conform to I.P. with respect to Assay of Sodium Chloride and DextroseAssay | CDL, KolkataCDSCO lab | Sep 2026 |
| Bupivacaine Hydrochloride in Dextrose Injection USP | Batch MN24369AMfg Mar 2025 · Exp Feb 2027 | Medizia BiotechHimachal Pradesh | The sample does not conform to U.S.P. with respect to test for 'pH', 'Visible Particulates In Injection' and is also not of standard quality for the reason stated under 'Description'.Description | CDL, KolkataCDSCO lab | Sep 2026 |
| Sodium Chloride And Dextrose Injection I.P. (0.9% w/v & 5% w/v) | Batch P260553007Mfg May 2026 · Exp Apr 2029 | Vision Parenteral Pvt. Ltd | The sample does not conform to IP with respect to Extractable Volume.Extractable volume | CDL, KolkataCDSCO lab | Aug 2026 |
| Bupivacaine Hydrochloride in Dextrose Injection USP 4ml | Batch BD25G2Mfg Aug 2025 · Exp Jul 2027 | Arco Lifesciences (I) Pvt. LtdMaharashtra | The sample does not conform to U.S.P. with respect to Assay of Dextrose AnhydrousAssay | CDL, KolkataCDSCO lab | Aug 2026 |
| Bupivacaine Hydrochloride In Dextrose Injection USP | Batch BKBP02601Mfg May 2026 · Exp Apr 2028 | Themis Medicare LtdMaharashtra | The sample does not conform to USP with respect to the test for pH and Bacterial Endotoxin.pH | CDL, KolkataCDSCO lab | Aug 2026 |
| BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP (Bupicain- HEAVY) | Batch BKBP O2601Mfg May 2026 · Exp Apr 2028 | Themis Medicare Limited | The sample does not conforms to the USP with respect to Bacterial Endotoxin.Bacterial endotoxins | DTL, JaipurState lab | Aug 2026 |
| Amino Acids (10%w/v) Injection with Electrolytes, Dextrose Injection IP (15%w/v) and Intravenous Fat Emulsion with Medium & Long Chain Triglycerides (20% w/v) in a Triple Chamber Bag | Batch 5D250116Mfg Apr 2025 · Exp Mar 2027 | Acculife Healthcare Pvt. LtdGujarat | The sample does not conform to claim with respect to Assay of L-Cysteine Hydrochloride Monohydrate, Sterility and Bacterial Endotoxin test of Infusion set.Assay | CDL, KolkataCDSCO lab | Jul 2026 |
| Sodium Chloride (0.9% w/v) & Dextrose (5%w/v) Injection IP | Batch PT25DNS2148CMfg Nov 2025 · Exp Oct 2028 | Promea Therapeutics Private LimitedTelangana | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab | Apr 2026 |
| Sodium Chloride and Dextrose Injection IP(0.9% W/V and 5% W/v) | Batch (N)251074Mfg Apr 2025 · Exp Mar 2027 | Klokter Lifesciences Pvt.Ltd Samora | The sample does not conform to I.P w.r.t Sterility TestSterility | DTL, Dalgate Srinagar Kashmir (J & K)State lab | Feb 2026 |
| Sodium Chloride and Dextrose Injection IP(0.9% W/V and 5% W/v) | Batch (N)251074Mfg Apr 2025 · Exp Mar 2027 | Klokter Lifesciences Pvt.Ltd Samora | The sample does not conform to I.P w.r.t Sterility TestSterility | DTL, Dalgate Srinagar Kashmir ( J and K)State lab | Jan 2026 |
| Bupivacaine Hydrochloride in Dextrose Injection USP | Batch BD24D2Mfg Dec 2024 · Exp Nov 2026 | Arco Lifesciences (I) Pvt. LtdMaharashtra | The sample does not conform to U.S.P. with respect to test for Visible Particulates In Injection and Description.Description | CDL, KolkataCDSCO lab | Jan 2026 |
| Bupivacaine Hydrochloride in Dextrose Injection USP (Bupivacaine Heavy) | Batch I-1468Mfg May 2024 · Exp Apr 2026 | Jackson Laboratories Pvt.Ltd 22-24Punjab | The sample does not conform to U.S.P. with respect to Assay of Dextrose.Assay | CDL, KolkataCDSCO lab | Oct 2025 |
| Multiple Electrolytes And Dextrose Injection Type I IP, | Batch P4BY04Mfg Feb 2025 · Exp Jan 2028 | Swaroop Pharmaceuticals Pvt. Ltd. A-10Uttar Pradesh | sample received does not conform to I.P. 2022 with respect to the test for Assay of magnesium and phosphateAssay | CDTL, MumbaiCDSCO lab | Sep 2025 |
Showing 15 of 40 records
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.